Skip to main content

Advertisement

SpringerLink
Log in

Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the long-term outcomes of total pancreatectomy in a modern cohort of pancreatic cancer patients and to establish whether any factors identified prior to pancreatic resection were related to poor survival.

Methods

We analyzed, retrospectively, patients who underwent total pancreatectomy for pancreatic cancer between 2007 and 2016. The short- and long-term outcomes were investigated and Cox regression analysis was used to evaluate the prognostic factors identified before resection.

Results

The subjects were 49 patients with a mean age of 65 years, who underwent total pancreatectomy in our hospital during the study period. Peritoneal washing cytology was performed in 48 patients, with positive results in 4 (8.3%). There was no 30-day mortality. The median overall survival was 22.5 months, with a 5-year survival rate of 28.5%. Univariate analyses of the pre-resection variables revealed that overall survival was associated with tumor location, resectability classification, maximum standardized uptake value of positron emission tomography, the preoperative carbohydrate antigen 19–9 level, and peritoneal washing cytology status. Multivariate analysis revealed that positive peritoneal washing cytology status and the maximum standardized uptake value were independent predictors of poor survival.

Conclusion

Total pancreatectomy for pancreatic cancer is appropriate for selected patients, but peritoneal washing cytology and positron emission tomography should be performed preoperatively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442.

    Article  PubMed  Google Scholar 

  2. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267–77. https://doi.org/10.1001/jama.297.3.267.

    Article  CAS  PubMed  Google Scholar 

  3. Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304(10):1073–81. https://doi.org/10.1001/jama.2010.1275.

    Article  CAS  PubMed  Google Scholar 

  4. Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388(10041):248–57. https://doi.org/10.1016/S0140-6736(16)30583-9.

    Article  CAS  PubMed  Google Scholar 

  5. Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389(10073):1011–24. https://doi.org/10.1016/S0140-6736(16)32409-6.

    Article  CAS  PubMed  Google Scholar 

  6. Rockey EW. Total pancreatectomy for carcinoma: case report. Ann Surg. 1943;118(4):603–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sarr MG, Behrns KE, van Heerden JA. Total pancreatectomy An objective analysis of its use in pancreatic cancer. Hepatogastroenterology. 1993;40(5):418–21.

    CAS  PubMed  Google Scholar 

  8. Ihse I, Anderson H, Andren S. Total pancreatectomy for cancer of the pancreas: Is it appropriate? World J Surg. 1996;20(3):288–93 (discussion 94.).

    Article  CAS  PubMed  Google Scholar 

  9. Roberts KJ, Blanco G, Webber J, Marudanayagam R, Sutcliffe RP, Muiesan P, et al. How severe is diabetes after total pancreatectomy? A case-matched analysis. HPB (Oxford). 2014;16(9):814–21. https://doi.org/10.1111/hpb.12203.

    Article  Google Scholar 

  10. Watanabe Y, Ohtsuka T, Matsunaga T, Kimura H, Tamura K, Ideno N, et al. Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life. World J Surg. 2015;39(5):1231–9. https://doi.org/10.1007/s00268-015-2948-1.

    Article  PubMed  Google Scholar 

  11. Hata T, Ishida M, Motoi F, Sakata N, Yoshimatsu G, Naitoh T, et al. Clinical characteristics and risk factors for the development of postoperative hepatic steatosis after total pancreatectomy. Pancreas. 2016;45(3):362–9. https://doi.org/10.1097/MPA.0000000000000462.

    Article  CAS  PubMed  Google Scholar 

  12. Hartwig W, Gluth A, Hinz U, Bergmann F, Spronk PE, Hackert T, et al. Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg. 2015;261(3):537–46. https://doi.org/10.1097/SLA.0000000000000791.

    Article  PubMed  Google Scholar 

  13. Johnston WC, Hoen HM, Cassera MA, Newell PH, Hammill CW, Hansen PD, et al. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the national cancer data base. HPB (Oxford). 2016;18(1):21–8. https://doi.org/10.1016/j.hpb.2015.07.009.

    Article  PubMed  Google Scholar 

  14. Satoi S, Murakami Y, Motoi F, Sho M, Matsumoto I, Uemura K, et al. Reappraisal of total pancreatectomy in 45 patients with pancreatic ductal adenocarcinoma in the modern era using matched-pairs analysis: multicenter study group of pancreatobiliary surgery in Japan. Pancreas. 2016;45(7):1003–9. https://doi.org/10.1097/MPA.0000000000000579.

    Article  PubMed  Google Scholar 

  15. Xiong J, Wei A, Ke N, He D, Chian SK, Wei Y, et al. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma. Int J Surg. 2017;48:134–41. https://doi.org/10.1016/j.ijsu.2017.10.065.

    Article  PubMed  Google Scholar 

  16. Reddy S, Wolfgang CL, Cameron JL, Eckhauser F, Choti MA, Schulick RD, et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009;250(2):282–7. https://doi.org/10.1097/SLA.0b013e3181ae9f93.

    Article  PubMed  Google Scholar 

  17. Japan Pancreas Society. Classification of Pancreatic Carcinoma. 4th English ed. Tokyo: Kanehara & Co., Ltd; 2017. https://www.suizou.org/pdf/Classification_of_Pancreatic_Carcinoma_4th_Engl_ed.pdf Accessed April 10 2019.

  18. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2.

    Article  PubMed  Google Scholar 

  19. ReMine WH, Priestley JT, Judd ES, King JN. Total pancreatectomy. Ann Surg. 1970;172(4):595–604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ihse I, Lilja P, Arnesjo B, Bengmark S. Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg. 1977;186(6):675–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Brooks JR, Brooks DC, Levine JD. Total pancreatectomy for ductal cell carcinoma of the pancreas. An update. Ann Surg. 1989;209(4):405–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nathan H, Wolfgang CL, Edil BH, Choti MA, Herman JM, Schulick RD, et al. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol. 2009;99(2):87–92. https://doi.org/10.1002/jso.21189.

    Article  PubMed  Google Scholar 

  23. Karpoff HM, Klimstra DS, Brennan MF, Conlon KC. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg. 2001;136(1):44–7 (discussion 8.).

    Article  CAS  PubMed  Google Scholar 

  24. Merchant NB, Conlon KC, Saigo P, Dougherty E, Brennan MF. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma. J Am Coll Surg. 1999;188(4):421–6.

    Article  CAS  PubMed  Google Scholar 

  25. Ferrone CR, Haas B, Tang L, Coit DG, Fong Y, Brennan MF, et al. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma. J Gastrointest Surg. 2006;10(10):1347–53. https://doi.org/10.1016/j.gassur.2006.07.013.

    Article  PubMed  Google Scholar 

  26. Yamada S, Fujii T, Kanda M, Sugimoto H, Nomoto S, Takeda S, et al. Value of peritoneal cytology in potentially resectable pancreatic cancer. Br J Surg. 2013;100(13):1791–6. https://doi.org/10.1002/bjs.9307.

    Article  CAS  PubMed  Google Scholar 

  27. Satoi S, Murakami Y, Motoi F, Uemura K, Kawai M, Kurata M, et al. Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection. J Gastrointest Surg. 2015;19(1):6–14. https://doi.org/10.1007/s11605-014-2637-7(discussion).

    Article  PubMed  Google Scholar 

  28. Abe T, Ohuchida K, Endo S, Ookubo F, Mori Y, Nakata K, et al. Clinical importance of intraoperative peritoneal cytology in patients with pancreatic cancer. Surgery. 2017;161(4):951–8. https://doi.org/10.1016/j.surg.2016.10.035.

    Article  PubMed  Google Scholar 

  29. Yachida S, Fukushima N, Sakamoto M, Matsuno Y, Kosuge T, Hirohashi S. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer. Br J Surg. 2002;89(5):573–8. https://doi.org/10.1046/j.1365-2168.2002.02061.x.

    Article  CAS  PubMed  Google Scholar 

  30. Meszoely IM, Lee JS, Watson JC, Meyers M, Wang H, Hoffman JP. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas. Am Surg. 2004;70(3):208–13 (discussion 13–4).

    PubMed  Google Scholar 

  31. Yoshioka R, Saiura A, Koga R, Arita J, Takemura N, Ono Y, et al. The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer. World J Surg. 2012;36(9):2187–91. https://doi.org/10.1007/s00268-012-1622-0.

    Article  PubMed  Google Scholar 

  32. Oh SY, Edwards A, Mandelson MT, Hahn H, Alseidi A, Biehl T, et al. Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-institution experience. Am J Surg. 2017;213(1):94–9. https://doi.org/10.1016/j.amjsurg.2016.04.008.

    Article  PubMed  Google Scholar 

  33. Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–25. https://doi.org/10.1056/NEJMoa1011923.

    Article  CAS  PubMed  Google Scholar 

  34. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691–703. https://doi.org/10.1056/NEJMoa1304369.

    Article  CAS  Google Scholar 

  35. Portal A, Pernot S, Tougeron D, Arbaud C, Bidault AT, de la Fouchardiere C, et al. Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort. Br J Cancer. 2015;113(7):989–95. https://doi.org/10.1038/bjc.2015.328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Marthey L, Sa-Cunha A, Blanc JF, Gauthier M, Cueff A, Francois E, et al. FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort. Ann Surg Oncol. 2015;22(1):295–301. https://doi.org/10.1245/s10434-014-3898-9.

    Article  CAS  PubMed  Google Scholar 

  37. Moningi S, Dholakia AS, Raman SP, Blackford A, Cameron JL, Le DT, et al. The role of stereotactic body radiation therapy for pancreatic cancer: a single-institution experience. Ann Surg Oncol. 2015;22(7):2352–8. https://doi.org/10.1245/s10434-014-4274-5.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Matsumoto I, Kamei K, Omae K, Suzuki S, Matsuoka H, Mizuno N, et al. FOLFIRINOX for locally advanced pancreatic cancer: results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan. Pancreatology. 2019;19(2):296–301. https://doi.org/10.1016/j.pan.2019.01.001.

    Article  CAS  PubMed  Google Scholar 

  39. Moon SY, Joo KR, So YR, Lim JU, Cha JM, Shin HP, et al. Predictive value of maximum standardized uptake value (SUVmax) on 18F-FDG PET/CT in patients with locally advanced or metastatic pancreatic cancer. Clin Nucl Med. 2013;38(10):778–83. https://doi.org/10.1097/RLU.0b013e31829f8c90.

    Article  PubMed  Google Scholar 

  40. Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S. 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg. 2003;7(8):953–9 (discussion 9–60).

    Article  PubMed  Google Scholar 

  41. Ariake K, Motoi F, Shimomura H, Mizuma M, Maeda S, Terao C, et al. 18-fluorodeoxyglucose positron emission tomography predicts recurrence in resected pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2017. https://doi.org/10.1007/s11605-017-3627-3.

    Article  PubMed  Google Scholar 

Download references

Funding

No grant support was obtained or used for this study.

Author information

Authors and Affiliations

  1. Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi Aoba-ku, Sendai, 980-8574, Japan

    Shimpei Maeda, Kyohei Ariake, Masahiro Iseki, Hideo Ohtsuka, Masamichi Mizuma, Kei Nakagawa, Takanori Morikawa, Hiroki Hayashi, Fuyuhiko Motoi, Takashi Kamei, Takeshi Naitoh & Michiaki Unno

Authors
  1. Shimpei Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyohei Ariake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahiro Iseki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideo Ohtsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masamichi Mizuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kei Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takanori Morikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroki Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Fuyuhiko Motoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takashi Kamei
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Takeshi Naitoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Michiaki Unno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shimpei Maeda.

Ethics declarations

Conflict of interest

We have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 28 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maeda, S., Ariake, K., Iseki, M. et al. Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy. Surg Today 50, 490–498 (2020). https://doi.org/10.1007/s00595-019-01924-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-019-01924-4

Keywords

Search

Navigation